Abstract

Stroke is a global burden. It is not known whether patients who are most at risk of stroke (recurrent stroke or recurrent transient ischaemic attack) have enough knowledge of stroke risk factors and warning signs. The aim of this study was to assess the knowledge of stroke risk factors and warning signs in this high-risk population. We performed a cross-sectional questionnaire-based study of patients with recurrent stroke or recurrent TIA admitted to Srinagarind Hospital and Khon Kaen Hospital, Thailand. A total of 140 patients were included in the study (age 65.6 ± 11.3 years [mean ± SD], 62 females). Using an open-ended questionnaire, nearly one-third of patients (31.4%) could not name any risk factors for stroke. The most commonly recognized risk factors were hypertension (35%), dyslipidemia (28.6%), and diabetes (22.9%). Regarding stroke warning signs, the most commonly recognized warning signs were sudden unilateral weakness (61.4%), sudden trouble with speaking (25.7%), and sudden trouble with walking, loss of balance, or dizziness (21.4%). Nineteen patients (13.6%) could not identify any warning signs. The results showed that knowledge of stroke obtained from open-ended questionnaires is still unsatisfactory. The healthcare provider should provide structured interventions to increase knowledge and awareness of stroke in these patients.

Highlights

  • IntroductionIn Thailand, stroke is the third leading cause of death [3] with approximately 250,000 patients suffering from stroke each year [4]

  • Stroke is one of the leading causes of adult disability worldwide [1, 2]

  • Recent evidence has shown that the administration of recombinant tissue plasminogen activator in patients with recurrent stroke improves neurological outcomes [5]

Read more

Summary

Introduction

In Thailand, stroke is the third leading cause of death [3] with approximately 250,000 patients suffering from stroke each year [4]. But this may not be the only effect of stroke: stroke recurrence, which has the cumulative risk of 25% in 5 years, increases the risk of severe disability and death [5]. Recent evidence has shown that the administration of recombinant tissue plasminogen activator (rtPA) in patients with recurrent stroke improves neurological outcomes [5]. A candidate for rtPA must arrive at the hospital without delay. Delayed arrival may be due to a lack of patient and public awareness of stroke symptoms, a decision to take a wait-andsee attitude, and a lack of proper immediate action [6, 7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call